NOV 24·GlobeNewswireLow
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
Files Definitive Proxy Statement for 2025 Annual Meeting of Stockholders ...
StockHealthcare · Biotechnology
$NEUP
Neuphoria Therapeutics Inc.
Price · $NEUPvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $NEUP in the last 7 days.
Insider · 30dFeed →
No SEC Form 4 filings for $NEUP in the last 30 days.
Top stories · $NEUPMore →
NOV 24·Benzinga
Neuphoria Therapeutics Inc. Sends Letter to Stockholders - Neuphoria Therapeutics ( NASDAQ:NEUP )
Files Definitive Proxy Statement for 2025 Annual Meeting of Stockholders Urges Stockholders to Vote "FOR" BOTH Neuphoria Therapeutics Nominees on WHITE Proxy Card
OCT 27·GlobeNewswire
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
BURLINGTON, Mass., Oct. 27, 2025 ( GLOBE NEWSWIRE ) -- Neuphoria Therapeutics Inc. ( "Neuphoria" or the "Company" ) ( Nasdaq: NEUP ) , a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced that its Board of Directors ( the "Board" ...